TipRanks
Go Ultimate55% OFF

PharmGen Science, Inc. (004720) Balance Sheet

PharmGen Science, Inc. Balance Sheet

PharmGen Science, Inc.'s total assets for Q2 2026 were $184.19B, a decrease of 7.47% from the previous quarter. KR:004720 total liabilities were $44.15B for the fiscal quarter, a 9.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 195.41B$ 363.45B$ 335.92B$ 317.39B$ 220.32B
$ 49.11B$ 114.02B$ 107.71B$ 110.28B$ 93.39B
$ 146.30B$ 249.43B$ 228.21B$ 207.12B$ 126.93B

Currency in KRW

PharmGen Science, Inc. Debt to Assets

0150B300B450B24 %32 %40 %48 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets